Isacoff & Flannery: Potential gene therapy for blindness

New research from the labs of MCB Professors Ehud Isacoff & John Flannery reports that insertion of a gene for a green-light receptor into the eyes of blind mice led to signs of reversed retinal degeneration. This gene therapy may soon be used to help restore vision in humans blindness due to retinal degeration.


Research setup
The new therapy involves injecting inactivated viruses into the vitreous to carry a gene directly into ganglion cells.